Oculus Innovative Sciences Announces Market Assessment of Near-Term Commercialization Opportunities in the United States for Dermacyn(TM) Wound Care Jun 2, 2008
Oculus Innovative Sciences Announces Publication of Microcyn(R) Technology Post-Caesarean Section Wound Study in Indian Medical Gazette May 28, 2008
Oculus Innovative Sciences to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto May 15, 2008
Oculus Innovative Sciences Announces Initial Chinese Commercialization Plan for Launch of Microcyn(R) Technology May 5, 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality Apr 23, 2008
Oculus Innovative Sciences' CEO and Founder Hoji Alimi Featured on NASDAQ CEO Signature Series Apr 17, 2008
Oculus Innovative Sciences Announces Publication of Microcyn(R) Technology Diabetic Wound Study in Journal of College of Physicians and Surgeons Pakistan Apr 15, 2008
Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Technology Mar 27, 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers Mar 17, 2008